APRE
Aprea Therapeutics Inc
NASDAQ: APRE · HEALTHCARE · BIOTECHNOLOGY
$0.82
-2.14% today
Updated 2026-04-29
Market cap
$9.81M
P/E ratio
—
P/S ratio
34.34x
EPS (TTM)
$-1.93
Dividend yield
—
52W range
$1 – $2
Volume
0.5M
Aprea Therapeutics Inc (APRE) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-79,206.00%
ROE
-74.60%
ROA
-41.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2007 | $67868.00 | $-3.52M | 80.24% | -4,670.09% | -5,193.06% |
| 2012 | $0.00 | $-254006.00 | — | — | — |
| 2013 | $0.00 | $-436215.00 | — | — | — |
| 2017 | $0.00 | $-15.19M | — | — | — |
| 2018 | $0.00 | $-15.53M | — | — | — |
| 2019 | $0.00 | $-28.06M | — | — | — |
| 2020 | $0.00 | $-53.92M | — | — | — |
| 2021 | $0.00 | $-36.54M | — | — | — |
| 2022 | $0.00 | $-112.66M | — | — | — |
| 2023 | $583231.00 | $-14.29M | 98.79% | -2,652.80% | -2,449.59% |
| 2024 | $1.50M | $-12.96M | -523.16% | -953.00% | -862.43% |
| 2025 | $285759.00 | $-12.60M | 92.40% | -4,631.12% | -4,409.16% |